Cardiac troponin I seems to be superior to cardiac troponin T in the early detection of cardiac injury associated with anthracycline treatment

Onkologie

Volumn 31, Issue 10, 2008, Pages 559-560

  Horacek, Jan M ^a,b   Pudil, Radek ^a   Tichy, Milos ^a,b   Jebavy, Ladislav ^a,b   Strasova, Alena ^a   Ulrychova, Martina ^a   Zak, Pavel ^a   Maly, Jaroslav ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; DAUNORUBICIN; IDARUBICIN; MITOXANTRONE; TROPONIN I; TROPONIN T;

ACUTE LEUKEMIA; ADULT; CANCER CHEMOTHERAPY; CARDIOMYOPATHY; CARDIOTOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART INJURY; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; IMMUNOASSAY; LETTER; MALE; PROTEIN BLOOD LEVEL; RECOMMENDED DRUG DOSE;

ANTHRACYCLINES; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TROPONIN I; TROPONIN T;

EID: 53949102045     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000151687     Document Type: Letter

References (10)

1. Shan K, Lincoff AM, Young JB: Anthracycline-induced cardiotoxicity. Ann Intern Med 1996;125:47-58.
2. Ganz WI, Sridhar KS, Ganz SS, Gonzalez R, Chakko S, Serafini A: Review of tests for monitoring doxorubicin-induced cardiomyopathy. Oncology 1996;53:461-470.
3. Meinardi MT, van der Graaf WT, van Veldhuisen DJ, Gietema JA, de Vries EG, Sleijfer DT: Detection of anthracycline-induced cardiotoxicity. Cancer Treat Rev 1999;25:237-247.
4. Sparano JA, Brown DL, Wolff AC: Predicting cancer therapy-induced cardiotoxicity. The role of troponins and other markers. Drug Saf 2002;25:301-311.
5. Fink FM, Genser N, Fink C, Falk M, Mair J, Maurer-Dengg K, Hammerer I, Puschendorf B: Cardiac troponin T and creatine kinase MB mass concentrations in children receiving anthracycline chemotherapy. Med Pediatr Oncol 1995;25:185-189.
6. Kismet E, Varan A, Ayabakan C, Kismet E, Varan A, Ayabakan C, Alehan D, Portakal O, Büyükpamukçu M: Serum troponin T levels and echocardiographic evaluation in children treated with doxorubicin. Pediatr Blood Cancer 2004;42:220-224.
7. Clark SJ, Pippon M, Hemsworth S, Newland P, Pizer B: Cardiac troponin T following anthracycline chemotherapy in children and adolescents. J Chemother 2007;19:332-334.
8. Auner HW, Tinchon C, Linkesch W, Tiran A, Quehenberger F, Link H, Sill H: Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies. Ann Hematol 2003;82:218-222.
9. Cardinale D, Sandri MT, Colombo A, Colombo N, Boeri M, Lamantia G, Civelli M, Peccatori F, Martinelli G, Fiorentini C, Cipolla CM: Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy. Circulation 2004;109:2749-2754.
10. Kilickap S, Barista I, Akgul E, Aytemir K, Aksoyek S, Aksoy S, Celik I, Kes S, Tekuzman G: CTnT can be a useful marker for early detection of anthracycline cardiotoxicity. Ann Oncol 2005;16:798-804.